Stallion India Fluorochemicals Share News - Latest Updates, Live News & More

Latest news about Stallion India Fluorochemicals

Stallion India Fluorochemicals' Rajasthan Plants to Benefit from RIPS 2024 Subsidies 7 days ago

Stallion India Fluorochemicals announced its R-32 and HFO manufacturing plants in Bhilwara, Rajasthan will benefit from comprehensive incentives under RIPS 2024, including capital subsidy for eligible fixed capital investment and multiple fiscal exemptions. The policy support significantly enhances project viability and return visibility for both facilities.

Stallion India Fluorochemicals Announces Rights Issue Worth Up To 3.64 Billion Rupees 9 days ago

Stallion India Fluorochemicals Makes Q1FY26 Earnings Conference Call Recording Available 10 days ago

Stallion India Fluorochemicals Partners with Sharjah Oxygen Company for Liquid Helium Sourcing Jan 30, 2026

Stallion India Fluorochemicals Submits Corrected Audio Recording Link for Q3 FY26 Earnings Call Jan 29, 2026

More news about Stallion India Fluorochemicals

29Jan 26

Stallion India Fluorochemicals Reports Strong Q3FY26 Performance with Strategic Expansion

Stallion India Fluorochemicals delivered strong Q3FY26 results with 23.17% revenue growth and 12.42% PAT increase, alongside impressive nine-month performance showing 41.69% revenue growth. The company announced strategic expansion including Environmental Clearance for 10,000 MT R-32 manufacturing facility and expects 30-35% CAGR growth over next three years.

28Jan 26

Stallion India Fluorochemicals Partners with Portugal's SYS ADVANCE for Helium Recovery Technology

Stallion India Fluorochemicals Limited has signed an MoU with Portugal-based SYS ADVANCE for technology collaboration in Helium Recovery and Liquefaction Systems. The partnership provides access to European Space Agency-qualified technology and supports Stallion's collaboration with ISRO for space applications. SYS ADVANCE operates over 4,000 PSA systems globally across 40+ countries. The company maintains its 30-35% revenue CAGR guidance over three years, supported by technological expansion and diversified operations.

26Jan 26

Stallion India Fluorochemicals Schedules Board Meeting for Q3FY26 Results on January 29, 2026

Stallion India Fluorochemicals Limited has scheduled a board meeting for January 29, 2026, to consider and approve Q3FY26 unaudited financial results covering the quarter and nine months ended December 31, 2025. The meeting will review both standalone and consolidated financial performance, with the announcement made in compliance with SEBI Listing Regulations through official notifications to NSE and BSE on January 24, 2026.

23Jan 26

Stallion India Fluorochemicals Board Approves Rights Issue Worth Up to ₹364 Crores

Stallion India Fluorochemicals Limited's board has approved a rights issue of equity shares worth up to ₹364.00 crores with a face value of ₹10.00 each. The company has formed a Rights Issue Committee to determine key parameters including issue price, share quantity, and rights ratio. The initiative will offer shares to eligible shareholders as on the record date, with detailed terms to be specified in the forthcoming Letter of Offer.

19Jan 26

Stallion India Fluorochemicals Secures Industrial Plot Allotment from RIICO for Expansion

Stallion India Fluorochemicals Limited has secured allotment of a 28,650 square meter industrial plot from RIICO in Ukhaliya, Rajasthan, under the Direct Allotment Policy-2025. The plot, designated as SP3-11, will support the company's long-term expansion plans and complement its existing R-32 Manufacturing Plant operations located at the adjacent Plot No. SP3-10 in the same industrial area.

19Jan 26

Stallion India Fluorochemicals Schedules Board Meeting for Fund Raising Proposal on January 21, 2026

Stallion India Fluorochemicals Limited has scheduled a board meeting for January 21, 2026, to consider fund raising proposals through equity shares or other securities via methods including rights issue. The company has implemented trading window restrictions effective immediately until 48 hours after the board meeting outcome publication, complying with insider trading prevention regulations.

29Dec 25

Stallion India Gets Green Nod for R32 Plant in Rajasthan

Stallion India Fluorochemicals has received environmental clearance to establish a new R32 refrigerant manufacturing facility in Bhilwara, Rajasthan. The plant will have an annual capacity of 10,000 MT of R32, a next-generation refrigerant used in air conditioning systems and heat pumps. The facility will also produce 46,460 MT of hydrochloric acid as a by-product annually. This approval is a significant step in the company's expansion strategy in the fluorochemicals sector and strengthens its position in India's growing HVAC industry.

24Nov 25

Stallion India Fluorochemicals Reaffirms 30-35% Revenue Growth Target for FY26

Stallion India Fluorochemicals has reaffirmed its revenue growth forecast of 30-35% for fiscal year 2026 (FY26). This ambitious target suggests significant anticipated business expansion and provides clear guidance to investors and stakeholders about the company's growth expectations. The forecast indicates the company's confidence in its business strategy and market position, with projected growth rates considerably higher than average market growth rates.

15Nov 25

Stallion India Fluorochemicals Reports Material Deviation in IPO Fund Utilization

Stallion India Fluorochemicals Limited (SFIL) has reported significant deviations in the utilization of its IPO proceeds, according to a Monitoring Agency Report by CARE Ratings Limited. The company exceeded allocated amounts for issue expenses by Rs. 3.99 crore and working capital by Rs. 3.71 crore. The deviation range is reported at 25-50% from the original plan. SFIL's board attributes the excess expenses to the IPO being oversubscribed 180 times. Despite these deviations, ongoing capital expenditure projects in Maharashtra and Andhra Pradesh are expected to be completed as scheduled by October 30, 2025.

12Nov 25

Stallion India Fluorochemicals: Stock Rebounds After Extreme Volatility

Stallion India Fluorochemicals, a Mumbai-based fluorochemicals company, saw its stock rise 5% on Tuesday after recent extreme fluctuations. The stock surged over 500% from mid-May to mid-October, followed by ten consecutive lower circuits that erased nearly half its value. The company, specializing in refrigerants and industrial gases, aims to grow its current 10% market share to 30-35% CAGR over the next three years. Financial performance shows strong growth with revenue increasing from ₹186.00 crore in FY22 to a projected ₹379.00 crore in FY25. The global fluorochemicals market is expected to grow over 10% annually, reaching $16.00 billion by 2028. However, technical analysis suggests caution with support at ₹190.00 and resistance at ₹260.00.

03Nov 25

Stallion India Fluorochemicals: Co-Promoter's Share Sale Bolsters R-32 Project in Bhilwara

Stallion India Fluorochemicals Limited's co-promoter has sold 16,20,987 shares, raising ₹45.74 crore to fund the R-32 production facility project in Bhilwara, Rajasthan. The entire proceeds will be infused into the company interest-free, demonstrating commitment to the project's timely commencement without diluting equity. Managing Director & CEO Shazad Rustomji emphasized the strategic importance of this move for the company's growth in the fluorochemicals sector.

24Oct 25

Stallion India Fluorochemicals Secures Environmental Clearance for ₹200 Crore R-32 Plant

Stallion India Fluorochemicals has secured environmental clearance from SEIAA Rajasthan for its ₹200 crore R-32 manufacturing plant project in Bhilwara. The clearance covers production of 10,000 MT R-32 annually, along with by-products and blended refrigerants, representing a significant regulatory milestone for the company's backward integration strategy.

16Oct 25

Stallion India Fluorochemicals Reports 56% Revenue Surge in Q2, PAT Soars to ₹1,141.67 Lakh

Stallion India Fluorochemicals Limited reported strong Q2 FY2025-26 results with revenue up 56% to ₹10,575.75 lakh and PAT surging 1,241% to ₹1,141.67 lakh. H1 FY2025-26 saw revenue increase 53% to ₹21,630.31 lakh and PAT rise 135% to ₹2,178.00 lakh. EBITDA margin improved to 14.91%. The company is expanding with new facilities in Andhra Pradesh and Maharashtra, targeting 30-35% CAGR over three years. Management expects profit margins to improve by 3-4% through strategic initiatives.

14Oct 25

Stallion India Fluorochemicals Reports Strong H1 FY25-26 Growth, On Track to Meet Annual Revenue Target

Stallion India Fluorochemicals Limited (SIFL) reported robust financial results for H1 FY25-26. Total revenue increased by 52.83% to ₹21,630.31 lakhs, EBITDA grew by 99.51% to ₹3,013.71 lakhs, and PAT surged by 135.03% to ₹2,178.00 lakhs compared to H1 FY24-25. Q2 FY25-26 saw exceptional growth with PAT rising by 1,224.61% to ₹1,141.67 lakhs. The company has achieved over 50% of its projected revenue for FY25-26 in the first half and maintains its revenue guidance of ₹43,000.00 lakhs for the full year. SIFL's growth is attributed to higher volumes, improved product mix, and operational efficiencies across key facilities.

13Oct 25

Stallion India Fluorochemicals Reports Strong Q2 Growth with Revenue Up 57% and Net Profit Surging to 114M Rupees

Stallion India Fluorochemicals Limited announced strong Q2 results with revenue increasing to 1.06 billion rupees, up 57% year-over-year. Net profit surged to 114.00 million rupees from 8.50 million rupees last year. EBITDA rose to 156.00 million rupees with margin expanding to 14.75%. The company's board approved the unaudited financial results and received a positive Limited Review Report from statutory auditors, affirming compliance with SEBI regulations.

29Aug 25

Stallion India Fluorochemicals Secures Land for New Manufacturing Plant in Bhilwara

Stallion India Fluorochemicals Limited has received approval for land allotment in Bhilwara, Rajasthan, to establish a new manufacturing plant. The allotment, granted by RIICO, follows an MoU with the Rajasthan government. The company is proceeding with registration formalities and taking physical possession of the land. This expansion is part of Stallion India's strategic growth plans in the fluorochemicals industry, potentially enhancing its market position and production capabilities.

12Aug 25

Stallion India Fluorochemicals Reports Strong Q1 FY2026 Results, Announces New R-32 Plant in Rajasthan

Stallion India Fluorochemicals Limited (SIFL) reported robust Q1 FY2026 results with total revenue up 50.30% to ₹11,054.55 lakhs, EBITDA increased by 12.73% to ₹1,436.94 lakhs, and net profit rose 23.14% to ₹1,036.32 lakhs. The company announced plans for a new ₹120 crore R-32 refrigerant gas manufacturing facility in Bhilwara, Rajasthan, set to start production in 2026. The facility will also produce other advanced refrigerant gases and is expected to create 30 direct jobs. SIFL is exploring opportunities in specialty and semiconductor gases, and investing in liquid helium processing capacity.

11Aug 25

Stallion India Fluorochemicals to Invest ₹120 Crore in R-32 Gas Manufacturing Facility

Stallion India Fluorochemicals Limited plans to establish a ₹120 crore manufacturing facility for R-32 gas in Bhilwara, Rajasthan. The company signed an MoU with the Rajasthan government for this project, which will also produce other refrigerant gases. The facility is expected to create 30 direct jobs and start production in 2026. This expansion aligns with Stallion's growth strategy, which includes developing a pan-India distribution network and investing in specialty gas capabilities. The company projects a 30-35% CAGR for the next three years and anticipates improved profit margins of 3-4%.

08Aug 25

Stallion India Fluorochemicals Reports Strong Q1 Performance with 50% Revenue Growth

Stallion India Fluorochemicals Limited (SIFL) announced strong Q1 results with total revenue up 50.30% year-on-year to ₹110.55 crore. Profit After Tax increased by 21.47% to ₹10.36 crore, while EBITDA grew 12.73% to ₹14.37 crore. The company's performance was driven by sustained demand and operational execution, despite challenges from border conflicts and early monsoons. SIFL remains confident in meeting its FY25-26 growth targets.

07Aug 25

Stallion India Fluorochemicals Unaffected by U.S. Tariff Changes, Company Confirms

Stallion India Fluorochemicals has officially announced that recent U.S. tariff changes will not impact its business operations or financial performance. The company clarified in a filing to the NSE and BSE that its operations, supply chains, and markets are not exposed to U.S. trade dynamics. The statement, signed by Company Secretary Govind Rao, assured stakeholders of no effect on the company's performance due to these tariff developments. Stallion India Fluorochemicals reaffirmed its commitment to growth and regulatory compliance, emphasizing transparency in its communication.